EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma

Suna Lin iD, Linjie Li, JiJun Chen, Zhaokun Tao, Lifeng Zhang, Junqing Mao, Jinhu Wang iD

Pediatric Blood & Cancer · 2026-10 · 73 (10)

DOI: 10.1002/1545-5017.70625 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 18.08.2026. Verfasst von Suna Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adol…. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dinutuximab beta, a monoclonal antibody targeting GD2, is crucial for treating high-risk neuroblastoma (HR-NB), with generally manageable side effects [ 1 ].ALK mutations or amplifications predict poor outcomes in HR-NB, but patients with these genetic changes may benefit from ALK inhibitors [ 2,3 ].Although both drugs are linked to gastrointestinal issues, their combined effect on gastric motility, such as acute gastric dilation, has not been documented.We report a pediatric case of acute gastric dilation from concurrent lorlatinib and dinutuximab beta treatment in refractory high-risk mediastinal neuroblastoma; symptoms resolved when the drugs were not given together.

Autor:innen und Institutionen

  • Department of Surgical Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents's Health and Diseases, Hangzhou, China.

ORCID-Profile: Suna Lin, Jinhu Wang

Förderung

  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province

Zitieren

APA

Lin, S., Li, L., Chen, J., Tao, Z., Zhang, L., Mao, J., & Wang, J. (2026). Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma. Pediatric Blood & Cancer, 73(10). https://doi.org/10.1002/1545-5017.70625

Vancouver

Lin S, Li L, Chen J, Tao Z, Zhang L, Mao J, et al. Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma. Pediatric Blood & Cancer. 2026;73(10). doi:10.1002/1545-5017.70625

BibTeX
@article{Lin2026,
  author = {Lin, Suna and Li, Linjie and Chen, JiJun and Tao, Zhaokun and Zhang, Lifeng and Mao, Junqing and Wang, Jinhu},
  title = {Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {10},
  doi = {10.1002/1545-5017.70625}
}
Kostenlos starten →